Ultragenyx Pharma (RARE) PT Lowered to $140 at Truist Securities

November 3, 2022 7:37 AM EDT
Get Alerts RARE Hot Sheet
Price: $50.85 +2.50%

Rating Summary:
    17 Buy, 5 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 16 | New: 24
Join SI Premium – FREE
Truist Securities analyst Joon Lee lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $140.00 (from $185.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change